Skip to main content

Table 1 Univariate analyses of baseline characteristics of HIV/CM inpatients in the derivative cohort

From: Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Variable

Survivors

Non-survivors

p-value

(n = 328)

(n = 58)

Demographic characteristics

 Age (years, IQR)

43(34,52)

54(44.8,65)

< 0.0001

 Male sex, n (%)

263 (80.2%)

40 (69.0%)

0.055

Comorbidity and Complications

 Cerebral infarction, n (%)

14 (4.3%)

5 (8.6%)

0.182#

 Liver cirrhosis, n (%)

5 (1.5%)

2 (3.4%)

0.284#

 Diabetes, n (%)

17 (5.2%)

5 (8.6%)

0.351#

 Tuberculosis, n (%)

47 (14.3%)

12 (20.7%)

0.215

 Pneumocystis pneumonia, n (%)

30 (9.1%)

6 (10.3%)

0.772

 Bacterial pneumonia, n (%)

48 (14.6%)

13 (22.4%)

0.134

 Cytomegalovirus infection

34 (10.4%)

7 (12.1%)

0.698

Clinical characteristic

 Time from symptom onset to hospital admission (month, IQR)

0.7(0.3,1.0)

1(0.3,2.0)

0.287

 Maximum body temperature (°C, IQR)

37.8 (36.7,39.0)

36.6 (36.7,38.3)

0.213

 Stiff neck, n (%)

24 (7.3%)

17 (29.3%)

< 0.0001

 Impaired consciousness, n (%)

28 (8.5%)

22 (37.9%)

< 0.0001

 Headache, n (%)

243 (74.1%)

45(77.6%)

0.572

 Seizures, n (%)

25 (7.6%)

7 (12.1%)

0.298#

 Weight loss, n (%)

125 (38.1%)

29 (50.0%)

0.088

Laboratory data

 CSF glucose (mmol/L, IQR)

2.54 (1.9,3.2)

2.25 (1.2,3.1)

0.045

 Neutrophil count (109/L, IQR)

3.4 (2.3,5.4)

3.8 (2.1,6.3)

0.419

 TBIL (μmol/L, IQR)

9.2 (7.0,13.6)

13.5 (9.0,19.7)

< 0.0001

 HGB (g/L, IQR)

115.0 (98.0,130.0)

108.0 (94.3126.0)

0.235

 PLT (×  106 /L, IQR)

186 (126.0,248.8)

120 (82,202)

< 0.0001

 Urea (mmol/L, IQR)

3.8 (3.0,5.5)

4.9 (3.7,6.8)

0.001

 Creatinine (μmol/L, IQR)

59.1 (49.0,71.2)

60.3 (49.1,75.6)

0.787

 White blood cell count (109/L, IQR)

4.6 (3.4,6.5)

4.7(3.1,7.2)

0.939

 CD4+ T-cell count (cells/μL, IQR)

32.0 (13.0,77.3)

29.0 (12.8,48.0)

0.095

 HIV RNA (log10 copies/mL, IQR)

5.1 (3.9,5.7)

5.4 (4.9,5.9)

0.009

 ICP (mm H2O, IQR)

215.0 (160.0,328.0)

360.0 (247.0,400.0)

< 0.0001

 ART at hospital admission, n (%)

198 (51.3%)

27(46.6%)

0.500

  1. Abbreviations: CSF cerebrospinal fluid, HGB hemoglobin, ICP intracranial pressure, TBIL total bilirubin, PLT platelet, ART antiviral therapy; p < 0.05 was considered statistically significant. # indicates the factors were calculated by the Fisher exact test, otherwise they were calculated by Pearson’s χ2 test